Jerry D Glickson

Title: Jerry D Glickson: Innovator in Antineoplastic Agents

Introduction

Jerry D Glickson is a notable inventor based in Ambler, PA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of targeted antineoplastic agents. His work focuses on improving the efficacy of cancer diagnostics and therapeutics.

Latest Patents

Glickson holds a patent for "Antineoplastic agents targeted via glut transporters." This invention relates to novel antineoplastic agents and cancer diagnostic agents that specifically target neo-plastic cells via the GLUT transportation system. More specifically, the invention involves conjugates of 2-deoxyglucose, wherein a linker, which includes a covalent bond, is attached to 2-deoxyglucose at the 2 position, and the linker is attached to a therapeutic or diagnostic agent. The invention also encompasses methods of treating tumor disease and methods of making the novel compounds. The agents developed by Glickson are superior to previous agents as they are specifically targeted via GLUT transporters. He has 1 patent to his name.

Career Highlights

Glickson is affiliated with the University of Pennsylvania, where he continues to advance his research in the field of cancer treatment. His work has garnered attention for its potential to improve patient outcomes through targeted therapies.

Collaborations

Throughout his career, Glickson has collaborated with esteemed colleagues such as Gang Zheng and Britton Chance. These collaborations have further enriched his research and contributed to the development of innovative cancer treatment strategies.

Conclusion

Jerry D Glickson is a pioneering inventor whose work in antineoplastic agents has the potential to transform cancer treatment. His innovative approach to targeting cancer cells through GLUT transporters represents a significant advancement in the field.